Compare US HB 8171 (2022) and US SB 209 (2025)
The introduced text of these two bills, side by side, with the wording they share.
- US HB 8171 (2022) · U.S. Congress · 2022 · Failed
- US SB 209 (2025) · U.S. Congress · 2025 · Pending
858 shared 8-word phrases found in the introduced text of these two bills.
This highlights wording the two bills share in their introduced text. A shared passage may include text that both bills quote from the same existing law, not only language either one drafted. A match shows that the texts overlap; it does not show who drafted a bill, and filing order alone does not show which bill copied which.
| US HB 8171 (2022) | US SB 209 (2025) |
|---|---|
| To protect children from medical malpractice in the form of gender transition procedures. IN THE | To protect children from medical malpractice in the form of gender-transition procedures. IN THE |
| A BILL To protect children from medical malpractice in the form of gender transition procedures. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE. 3 This Act may be cited as the | A BILL To protect children from medical malpractice in the form of gender-transition procedures. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE. 3 This Act may be cited as the |
| SEC. 2. PRIVATE RIGHT OF ACTION FOR A GENDER-TRANSI- 1 TION PROCEDURE PERFORMED ON A MINOR. 2 (a) IN GENERAL.—A medical practitioner, in any cir- 3 cumstance described in subsection (c), who performs a 4 gender-transition procedure on an individual who is less | SEC. 2. PRIVATE RIGHT OF ACTION FOR A GENDER-TRANSI- 6 TION PROCEDURE PERFORMED ON A MINOR. 7 (a) IN GENERAL.—A medical practitioner, in any cir- 8 cumstance described in subsection (c), who performs a 9 gender-transition procedure on an individual who is less |
| than 18 years of age shall, as described in subsection (b), 6 be liable to the individual if injured (including any phys- 7 ical, psychological, emotional, or physiological harms) by 8 such procedure, related treatment, or the aftereffects of 9 the procedure or treatment. 10 (b) PRIVATE RIGHT OF ACTION.—An individual cov- 11 ered by subsection (a) who receives a gender-transition 12 procedure from a medical practitioner (or a representative, 13 including a legal guardian, on behalf of such individual) 14 may, not later than the day that is 30 years after the date 15 on which the individual turns 18 years of age, bring a civil 16 action against such medical practitioner in a court of com- 17… | than 18 years of age shall, as described in subsection (b), 1 be liable to the individual if injured (including any phys- 2 ical, psychological, emotional, or physiological harms) by 3 such procedure, related treatment, or the aftereffects of 4 the procedure or treatment. 5 (b) PRIVATE RIGHT OF ACTION.—An individual cov- 6 ered by subsection (a) who receives a gender-transition 7 procedure from a medical practitioner (or a representative, 8 including a legal guardian, on behalf of such individual) 9 may, not later than the day that is 30 years after the date 10 on which the individual turns 18 years of age, bring a civil 11 action against such medical practitioner in a court of com- 12 pete… |
| the medical practitioner or the individual re- 1 ceiving the gender-transition procedure traveled in 2 interstate or foreign commerce, or traveled using a 3 means, channel, facility, or instrumentality of inter- 4 state or foreign commerce, in furtherance of or in | the medical practitioner or the individual re- 21 ceiving the gender-transition procedure traveled in 22 interstate or foreign commerce, or traveled using a 23 means, channel, facility, or instrumentality of inter- 24 state or foreign commerce, in furtherance of or in |
| foreign commerce, in furtherance of or in 5 connection with the conduct described in subsection 6 (a | foreign commerce in furtherance of or in connection 5 with the conduct described in subsection (a |
| means, 8 channel, facility, or instrumentality of interstate or 9 foreign commerce | means, channel, 16 facility, or instrumentality of interstate or foreign 17 commerce |
| or instrumentality of interstate or foreign 22 commerce or in or affecting interstate or foreign 23 commerce by any means or in any manner, including | or instrumentality of interstate or foreign 17 commerce or in or affecting interstate or foreign 18 commerce by any means or in any manner, including |
| by computer, mail, wire, or electromagnetic trans- 1 mission; 2 (5) any instrument, item, substance, or other 3 object that has traveled in interstate or foreign com- 4 merce was used to perform the conduct described in 5 subsection (a | by computer, mail, wire, or electromagnetic trans- 20 mission; 21 (5) any instrument, item, substance, or other 22 object that has traveled in interstate or foreign com- 23 merce was used to perform the conduct described in 24 subsection (a |
| the conduct described in subsection (a) oc- 7 curred within the special maritime and territorial ju- 8 risdiction of the United States, or any territory or 9 possession of the United States; or 10 (7) the conduct described in subsection (a) oth- 11 erwise occurred in or affected interstate or foreign 12 commerce. 13 SEC. 3. PRESERVING FREEDOM OF CONSCIENCE AND MED- 14 ICAL JUDGEMENT FOR MEDICAL PROVIDERS. 15 Notwithstanding any other provision of law, no provi- 16 sion of Federal law shall require, or be construed to re- 17 quire, a medical practitioner to perform a gender-transi- 18 tion procedure. 19 SEC. 4. PROHIBITION ON FUNDING FOR CERTAIN STATES. 20 Notwithstanding any other provision… | the conduct described in subsection (a) oc- 1 curred within the special maritime and territorial ju- 2 risdiction of the United States, or any territory or 3 possession of the United States; or 4 (7) the conduct described in subsection (a) oth- 5 erwise occurred in or affected interstate or foreign 6 commerce. 7 SEC. 3. PRESERVING FREEDOM OF CONSCIENCE AND MED- 8 ICAL JUDGEMENT FOR MEDICAL PROVIDERS. 9 Notwithstanding any other provision of law, no provi- 10 sion of Federal law shall require, or be construed to re- 11 quire, a medical practitioner to perform a gender-transi- 12 tion procedure. 13 SEC. 4. PROHIBITION ON FUNDING FOR CERTAIN STATES. 14 Notwithstanding any other provision of la… |
| SEC. 5. DEFINITIONS. 1 In this Act: 2 (1) BIOLOGICAL SEX.—The term ‘‘biological 3 sex’’ means the genetic classification of an individual 4 as male or female, as reflected in the organization 5 of the body of such individual for a reproductive role | SEC. 5. DEFINITIONS. 20 In this Act: 21 (1) BIOLOGICAL SEX.—The term ‘‘biological 22 sex’’ means the genetic classification of an individual 23 as male or female, as reflected in the organization 24 of the body of such individual for a reproductive role |
| or capacity, such as through sex chromosomes, natu- 7 rally occurring sex hormones, and internal and ex- 8 ternal genitalia present at birth, without regard to 9 the subjective sense of identity of the individual. 10 (2) GENDER-TRANSITION PROCEDURE.— 11 (A) IN GENERAL.—Except as provided in 12 subparagraph (B), the term ‘‘gender-transition 13 procedure’’ means— 14 (i) the prescription or administration 15 of puberty-blocking drugs for the purpose 16 of changing the body of an individual so 17 that it conforms to the subjective sense of 18 identity of the individual, in the case such 19 identity is at odds with the individual’s bi- 20 ological sex; 21 (ii) the prescription or administration… | or capacity, such as through sex chromosomes, natu- 1 rally occurring sex hormones, and internal and ex- 2 ternal genitalia present at birth, without regard to 3 the subjective sense of identity of the individual. 4 (2) GENDER-TRANSITION PROCEDURE.— 5 (A) IN GENERAL.—Except as provided in 6 subparagraph (B), the term ‘‘gender-transition 7 procedure’’ means— 8 (i) the prescription or administration 9 of puberty-blocking drugs for the purpose 10 of changing the body of an individual so 11 that it conforms to the subjective sense of 12 identity of the individual, in the case such 13 identity is at odds with the individual’s bi- 14 ological sex; 15 (ii) the prescription or administration 16 of… |
| identity is at odds with the individual’s bi- 1 ological sex; or 2 (iii) a surgery to change the body of 3 an individual so that it conforms to the 4 subjective sense of identity of the indi | identity is at odds with the individual’s bi- 21 ological sex; or 22 (iii) a surgery to change the body of 23 an individual so that it conforms to the 24 subjective sense of identity of the indi |
| vidual, in the case such identity is at odds 6 with the individual’s biological sex. 7 (B) EXCEPTION.—The term ‘‘gender-tran- 8 sition procedure’’ does not include— 9 (i) an intervention described in sub- 10 paragraph (A) that is performed on— 11 (I) an individual with biological 12 sex characteristics that are inherently 13 ambiguous, such as those born with 14 46 XX chromosomes with virilization, 15 46 XY chromosomes with 16 undervirilization, or having both ovar- 17 ian and testicular tissue; or 18 (II) an individual with respect to 19 whom a physician has determined 20 through genetic or biochemical testing 21 that the individual does not have nor- 22 mal sex chromosome structure, sex 2… | vidual, in the case such identity is at odds 1 with the individual’s biological sex. 2 (B) EXCEPTION.—The term ‘‘gender-tran- 3 sition procedure’’ does not include— 4 (i) an intervention described in sub- 5 paragraph (A) that is performed on— 6 (I) an individual with biological 7 sex characteristics that are inherently 8 ambiguous, such as those born with 9 46 XX chromosomes with virilization, 10 46 XY chromosomes with 11 undervirilization, or having both ovar- 12 ian and testicular tissue; or 13 (II) an individual with respect to 14 whom a physician has determined 15 through genetic or biochemical testing 16 that the individual does not have nor- 17 mal sex chromosome structure, sex 18 ste… |
| steroid hormone action, for a biologi- 1 cal male or biological female; 2 (ii) the treatment of any infection, in- 3 jury, disease, or disorder that has been 4 caused or exacerbated by the performance 5 of an intervention described in subpara | steroid hormone action, for a biologi- 20 cal male or biological female; 21 (ii) the treatment of any infection, in- 22 jury, disease, or disorder that has been 23 caused or exacerbated by the performance 24 of an intervention described in subpara |
Only the first shared passages are listed here; the side-by-side view shows them all.